Pathogenic dominant variants in FGB cause reduced levels of fibrinogen, altered fibrinogen activity, or both, which predisposes to either arterial/venous thromboses or a bleeding disorder [61]. The gene discussed is FGB; the disease is hemorrhagic disease.